The indications for percutaneous endoscopic gastrostomy (PEG) and patient outcome, were examined prospectively in the setting of a general hospital. In the course of 26 months, 76 patients underwent PEG (median age 62 years (range 18-99)) and were followed up for 6887 patient days. The median (range) duration of PEG feeding was 93 (3-785) days. The procedure was carried out for neurological indications in 76% of cases (stroke 51%) and 53% of patients were severely malnourished (body mass index <17 kg/M2) at the time of referral. In 12 (16%) patients swallowing recovered and the PEG was removed after a median (range) of 55 days 
Abstract
The indications for percutaneous endoscopic gastrostomy (PEG) and patient outcome, were examined prospectively in the setting of a general hospital. In the course of 26 months, 76 patients underwent PEG (median age 62 years (range 18-99)) and were followed up for 6887 patient days. The median (range) duration of PEG feeding was 93 (3-785) days. The procedure was carried out for neurological indications in 76% of cases (stroke 51%) and 53% of patients were severely malnourished (body mass index <17 kg/M2) at the time of referral. In 12 (16%) patients swallowing recovered and the PEG was removed after a median (range) of 55 days (20-150). Three (4%) deaths were related to PEG (one oesophageal perforation, one haemorrhage, and one aspiration pneumonia). One patient developed peritonism and ileus, which resolved with conservative treatment. Minor complications included local sepsis 3%, tube blockage 12%, and tube connector leak 5%. During seven days of observation, demands on nursing time for routine care of the PEG were the same as for nasogastric tube feeding, median (range) 21 (4-42) v 16 min/day respectively, but in about half the latter cases the tube had to be replaced at least once. Over 15 months, 29 patients were randomised to receive a 1 9 mm inner, [2] [3] [4] [5] [6] [7] [8] [9] mm (9F) outer diameter Fresenius and 27 a 3 0 mm inner, 4 0 mm (12F) outer diameter Bower polyurethane tube and were followed for 2920 and 2388 patient days respectively. There was no difference in the insertion time (median (range) 20 (10-45) v 24 (10-45) min respectively) or number of patients with complications (three v eight patients NS), although there were more minor mechanical problems (three v 12, p<0.01) with the 12F tube. The internal anchoring device of the 12F tube allowed its non-endoscopic removal, a method applicable to 16% of cases. No tubes were removed because of blockage. (Gut 1994; 35: [1551] [1552] [1553] [1554] [1555] [1556] Since it was first described in 1980,1 percutaneous endoscopic gastrostomy (PEG) has been increasingly adopted and a number of studies have reported a low incidence of complications.2-5 Increasing evidence of its safety and the wider availability of endoscopic skills make it likely that the use of PEG will spread in general hospitals. This study aimed to examine prospectively the indications for PEG in a district general hospital, to compare the demands on nursing resources of PEG versus nasogastric tube (NG) feeding, and to conduct prospective long term follow up of patients in order to determine patient outcomes of PEG. During the course of the study, we conducted a randomised comparison of two commercially available PEG tubes with lumens of different diameters.
Patients and methods

INDICATIONS FOR PEG AND DEMANDS ON NURSING RESOURCES OF PEG VERSUS NASOGASTRIC TUBE FEEDING
Birmingham Heartlands (previously East Birmingham) is a general hospital serving a resident population of 300 000. The study was conducted between November 1990 and January 1993. Inpatients and ambulant outpatients with impaired swallowing and a nutritional need for enteral feeding expected to exceed two weeks were considered for the study. Inclusion criteria for inpatients were an inability to tolerate a nasogastric tube on at least two occasions or the presence of an oesophageal abnormality contraindicating the use of a nasogastric tube. Outpatient inclusion criteria were either as above or a requirement for long term enteral nutrition for patients who opted for PEG in preference to a nasogastric tube for convenience and cosmetic reasons. Exclusion criteria were current chest infection, ascites, portal hypertension, active gastric ulcer, total gastrectomy, and uncorrected coagulopathy.
The endoscopic team were not, by and large, involved in ethical decisions as to whether PEG feeding was appropriate long term management. After referral for PEG, patients were assessed by two members of our multidisciplinary nutrition team (MZPmedical and HR-dietitian) for eligibility. At entry, the patient's age, main diagnosis, presence of other morbid conditions, weight, and height were recorded and the body mass index (BMI) was derived (kg/M2). Body composition was estimated in terms of body fat and muscle by measuring triceps skinfold thickness and mid-arm muscle circumference, using Holtain skinfold calipers and an inelastic tape on the non-dominant arm, as previously described.67 At entry (after discussion with the team caring for the patient and taking into account the nature of the underlying disease and all available clinical information), a prediction was made as to whether PEG feeding would be required only for a few weeks to months or for an indefinite period. PEG tubes used for this study were the 1-9 mm inner 2-9 mm (9F) outer diameter (Fresenius, Homberg, Germany) and the 3 0 mm inner 4 Patients were reviewed at one, two, and four weeks, and monthly thereafter, until PEG removal or death. At each follow up visit weight, triceps skinfold thickness, and midarm muscle circumference were measured and body mass index was derived, and the presence or absence of the following complications was recorded: infection of insertion site, episodes of septicaemia, evidence for aspiration pneumonia, onset of gastrointestinal disturbance (diarrhoea or vomiting), tube blockage, tube fracture, and leakage from tube connection points. At each review, patients and carers were asked to list any other adverse events. After death, case notes were reviewed in order to ascertain, as far as possible, the cause of death.
PROSPECTIVE RANDOMISED COMPARISON OF TWO PEG TUBES
Between November 1991 and January 1993, patients were randomised to receive either the 9F Fresenius or the 12F Bower PEG tube, after contraindications were excluded by diagnostic oesophago-gastroduodenoscopy. Feed was delivered either by continuous infusion over 20-24 hours, or in cases requiring only overnight supplemental nutrition (such as patients with cystic fibrosis) over eight to 10 hours. The feeding rate was controlled using an enteral feeding pump (Flexiflo pump, Abbott Laboratories, Maidenhead, Berks, UK).
The following variables were examined prospectively in respect of each tube: time taken for PEG insertion, local sepsis, frequency of blockage, leakage from tube connections, tube fracture, and ease of removal.
Statistical (Table IV) .
There were few minor complications of PEG. In two patients (2%) there was infection at the PEG insertion site at 77 and 150 days after the procedure. There were six episodes of diarrhoea in six patients (8%) in the first 30 days of PEG feeding which resolved with simple measures (Table IV) . Clostridium difficile was detected in the stool of two of these, but C difficile toxin was absent. Two mechanical problems was greater in the 12F Bower group (Table V) . Five of these episodes were due to leakage from the feeding tube-hub connector system. In one case (9F, Fresenius), fracture of the tube occurred near the hub and this was rectified by shortening the tube and replacing the hub. There were seven instances of blockage in five patients in the 1 2F and two episodes in one patient in the 9F group. No PEG was removed or replaced because of blockage. Three patients from the 9F (Fresenius) group recovered sufficiently to allow removal of the tube by endoscopy, while in five of six patients, the 12F (Bower) tube was removed non-endoscopically.
Discussion
Previous prospective studies of PEG in hospital patients reported its use in selected groups, such as those in persistent vegetative states,5 the elderly,9 patients with neurological problems in teaching hospitals,'0 or young patients with cystic fibrosis." This study indicates that using our inclusion criteria, in a patient population from a district general hospital, stroke accounts for half of all cases in whom PEG may be employed, while neurological causes as a whole account for three quarters. Two thirds of stroke patients were referred within four weeks of hospital admission and only a small proportion of these were severely malnourished at the time of referral. In this group, there was no correlation between longer hospital stay before PEG and the degree of malnutrition. These findings suggest that in stroke patients delayed referral was not a major problem. The 10 Park et al,5 reported greater weight gain with PEG than nasogastric tube feeding in the first week. This finding was attributed to greater dietary intake during uninterrupted periods of feed administration. Interruptions to nasogastric tube feeding were common because of tube displacement.5 10 13 Our data on demands on nursing time for PEG and nasogastric tube feeding suggest that while there was no difference in the time spent in the routine care of the PEG and nasogastric tube, the frequent need for replacing the latter should result in a greater overall demand on nurses time by nasogastric tube feeding. The absence of a significant difference between the two in our study probably reflects a bias introduced by a short period of observation of seven days. An additional expense in the case of nasogastric tube feeding is the cost of radiology, which is often needed to confirm the position of a replaced tube.
The low incidence of mortality (4%) and major complications (2%) and the low frequency of minor complications in our study compare favourably with results from prospective studies in teaching hospitalsl' and in highly selected patient groups,5 9 10 and agree with data from large retrospective series of general patient populations.24 The long term outcome in our patients is broadly similar to results of an audit of outcome reported by Hull et al from a series of 49 patients,'2 although there are some important differences. In particular, the higher 30 day mortality in the present series (26% compared with 8% in Hull's series) probably reflects patient selection. This is suggested by the fact that in Hull's study, 34 of 49 (69%) patients entered were able to return home, while in our series, with the exception of the 13 (17%) cases who were outpatients at the time of entry, all remained in hospital or were transferred to a nursing home.
In as many as 16% of patients the primary reason for PEG insertion resolved sufficiently to enable removal of the PEG. This was predicted correctly in only half of the patients. In our assessment of predictability we did not use predefined criteria because we had anticipated a diversity of problems in individual patients with varying severity of disease. In future studies it may be worthwhile to examine the usefulness of predefined criteria in predicting recovery. Our observation of poor predictability suggests that (at least until reliable predictors of reversibility can be identified) wider consideration should be given to PEG tubes that allow non-endoscopic removal, in order to minimise demands on resources and the small but finite risk of complications arising from a second endoscopy. The increasing practice of using 'exchange' gastrostomy tubes inserted by the 'push' technique through an already established fistulous tract, is an additional reason for preferring a non-endoscopically removable tube. In choosing between the 9F (Fresenius) and the 1 2F (Bower) tubes, the comparative costs of these devices must be taken into account. Although prices may vary between countries, in the United Kingdom the costs of the Fresenius (9F) and the Bower (12F) tubes are £35.00 and £82.00 (exclusive of value added tax) respectively.
We have become aware that some endoscopists avoid a second endoscopy for removal of the 9F Fresenius tube by cutting it at the skin and allowing the intragastric anchor to pass through the pylorus and finally in the stool. This is not our practice because we consider that inherent in this method is a small risk of small bowel obstruction (especially if there is unsuspected stricture) or entrapment in a diverticulum, which may result in erosion or perforation of the bowel.
Two patients with complications merit further discussion. The first, died of aspiration pneumonia five months after PEG insertion. Although we include him in our death rate of 4%, it is debatable whether this death was directly attributable to PEG, since aspiration pneumonia is not uncommon in bed-ridden debilitated patients, whether fed by mouth, nasogastric tube, or PEG. It is possible that gastro-jejunostomy tube feeding may reduce the risk of aspiration. The second, is the patient with cystic fibrosis who developed peritonism and ileus after PEG insertion. We believe that this was due to laceration of the stomach during the insertion procedure. This risk could be reduced by more generous sedation and analgesia, while monitoring oxygen saturation by pulse-oximeter. We have discussed this case in detail in a previous letter.14 Mechanical complications identified were tube blockage and leakage. Inquiry into the circumstances under which these occurred, suggested that the former was due to inadequate flushing of the tube between feeds and before and after drug administration. This problem seemed to be common on long stay wards with a low ratio of nurses to patients. In this context, it is interesting that there were no instances of tube blockage where patients or family members were caring for the PEG. Better education and training of nursing staff in the care of PEG (in addition to the minimum given in the present study) or using a nurse specialist in nutrition, or both, could reduce the frequency of tube blockage. Tube blockage was more common (though not significantly) with the wider diameter 12F Bower tube but this seemed to be related to poor nursing care rather than to an intrinsic problem with the device. Consistent with this interpretation is the observation that seven of nine episodes of blockage occurred in the first month of PEG feeding, and rarely recurred later (Table IV) . Leakage was a problem encountered with the Bower tube at the site of the tube connection to the hub. This was because of a defect in the tube-hub connector device which was rectified by the manufacturer and the problem was not encountered in the latter part of our series. Nevertheless, this resulted in a statistically significant increased frequency of minor mechanical problems in the Bower group.
The technical procedure of PEG insertion was equally easy with the 12F Bower and the 9F Fresenius tubes and we did not encounter specific problems with either. With increasing experience, in the latter part of the study, the time taken to complete the procedure rarely exceeded 15 minutes.
PEG feeding is effective in a general hospital population and can be of benefit in patients requiring feeding for only a few weeks. Further prospective studies to assess the predictability of recovery may be helpful in the choice of PEG tube design.
